Diabetes Care: The relationship between SGLT2 inhibitors and the risk of retinal vein occlusion in patients with type 2 diabetes
Hausen even reported 2 innovative drugs!
Australia and New Zealand publicly solicits opinions on the application of 2'-fucosyllactose in infant formula and infant formula supplements
American Journal of Nutrition: Consumption of dairy products may reduce the risk of type 2 diabetes
Zhang Wenhong: The key to the Nanjing epidemic depends on the follow-up 1-2 weeks of monitoring
SARS-CoV-2 vaccine mixed vaccination may be more effective
CELL: The local intrinsic immunity of severely ill patients with SARS-CoV-2 infection is impaired
Zhoushan spot-checked 2 batches of building interior putty products with a batch failure rate of 0
Tanabe Mitsubishi's "Titagliptin Tablets" for the treatment of type 2 diabetes will soon be approved
NeuroImage: Walking 2 hours a week can effectively prevent memory loss!
The highest daily detection throughput is 2 million copies!
Reduce liver fat levels and improve kidney function NASH therapy reaches the primary phase 2 clinical endpoint
Announcement of the Zhanjiang Municipal Market Supervision Administration on the unqualified status of 10 batches of food (No. 2 of 2021)
NEJM: What are the long-term complications of young-onset type 2 diabetes patients?
of Ya'an Food Safety "Check Your Points" in 2021 (No. 2 of 2021)
17 new confirmed cases on the 7th, 2 local cases are in Yunnan
NEJM: For the treatment of type 2 diabetes, Tirzepatide is better than Semaglutide!
Lancet Infect Dis: The safety and immunogenicity of the SARS-CoV-2 inactivated vaccine BBIBP-CorV
"Nature Medicine" "Combination" shows how SARS-CoV-2 infects brain cells
Luoxin Pharmaceutical and HK inno.N of South Korea join hands again, aiming at the US$2 billion Chinese PPI injection market